| Line Item | 2024-05-26 | Y/Y |
|---|---|---|
| Revenue | $128.3M | +24.2% |
| Cost of Revenue | $86.4M | +14.8% |
| Gross Profit | $41.9M | +49.5% |
| R&D Expense | $8.6M | -1.8% |
| SG&A Expense | $40.5M | +3.8% |
| Operating Income | -$8.8M | +59.4% |
| Pre-tax Income | $9.5M | +114.9% |
| Income Tax | $183K | -40.6% |
| Net Income | $12.0M |
| Line Item | 2024-05-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | -55.7% |
| Accounts Receivable | $31.2M | +7.3% |
| Inventory | $40.0M | -2.1% |
| Current Assets | $81.0M | -13.7% |
| Total Assets | $254.0M | +0.2% |
| Current Liabilities | $38.9M | -1.1% |
| Long-term Debt | $101.6M | +19.8% |
| Line Item | 2024-05-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$217K | +98.8% |
| Investing Cash Flow | -$17.9M | -272.5% |
| Financing Cash Flow | $7.5M | -81.1% |
| +112.1% |
| EPS (Basic) | $0.40 | +112.0% |
| EPS (Diluted) | $0.32 | +109.6% |
| Total Liabilities |
| $200.1M |
| -8.4% |
| Stockholders' Equity | $11.3M | +367.5% |